FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034509216> ?p ?o ?g. }

• W2034509216 endingPage "1826" @default.
• W2034509216 startingPage "1818" @default.
• W2034509216 abstract "Based on animal studies and pilot studies in humans, betaine, a methyl donor for the remethylation of homocysteine, may be a therapeutic agent for nonalcoholic steatohepatitis (NASH). We evaluated the safety and efficacy of betaine for patients with NASH and whether betaine positively modified factors postulated to be second hits and underlying mechanisms of NASH. We conducted a randomized placebo-control study of 55 patients with biopsy-proven NASH who received either oral betaine (20 g daily) or placebo for 12 months. Pre- and posttreatment variables were analyzed using the paired t test or Wilcoxon rank test. Treatment groups were comparable at baseline. Of the 35 patients (17 betaine, 18 placebo) who completed the study, 34 patients (16 betaine, 18 placebo) underwent posttreatment liver biopsy. Patients randomized to betaine had a decrease in steatosis grade. No intra- or intergroup differences or changes in nonalcoholic fatty liver disease activity score or fibrosis stage were noted. Elevations of insulin, glucose, and proinflammatory cytokines and the reduced antioxidant status noted in NASH patients did not improve with betaine therapy. The antiinflammatory agent adiponectin was significantly reduced in both groups and did not change with therapy. Lastly, S-adenosylhomocysteine was approximately twice normal and was not reduced by betaine therapy.Compared to placebo, betaine did not improve hepatic steatosis but may protect against worseningsteatosis [corrected]. High-dose betaine supplementation failed to reduce S-adenosylhomocysteine and did not positively affect any of the second hit mechanisms postulated to contribute to NASH that we studied. Although betaine has been proven effective in treating hepatic steatosis in several animal models, translating novel therapeutic options noted in animal studies to humans with NASH will prove challenging." @default.
• W2034509216 created "2016-06-24" @default.
• W2034509216 creator A5003360183 @default.
• W2034509216 creator A5010606656 @default.
• W2034509216 creator A5011743267 @default.
• W2034509216 creator A5012100988 @default.
• W2034509216 creator A5013395050 @default.
• W2034509216 creator A5020828316 @default.
• W2034509216 creator A5022042238 @default.
• W2034509216 creator A5026951492 @default.
• W2034509216 creator A5071407810 @default.
• W2034509216 creator A5083171885 @default.
• W2034509216 creator A5086610543 @default.
• W2034509216 date "2009-08-17" @default.
• W2034509216 modified "2023-10-16" @default.
• W2034509216 title "Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial" @default.
• W2034509216 cites W1975933510 @default.
• W2034509216 cites W1978152806 @default.
• W2034509216 cites W1998165917 @default.
• W2034509216 cites W2001671445 @default.
• W2034509216 cites W2007146576 @default.
• W2034509216 cites W2013635918 @default.
• W2034509216 cites W2054601149 @default.
• W2034509216 cites W2055518919 @default.
• W2034509216 cites W2074354128 @default.
• W2034509216 cites W2076876812 @default.
• W2034509216 cites W2081308182 @default.
• W2034509216 cites W2087829753 @default.
• W2034509216 cites W2090623873 @default.
• W2034509216 cites W2092860379 @default.
• W2034509216 cites W2098555833 @default.
• W2034509216 cites W2102095802 @default.
• W2034509216 cites W2102866245 @default.
• W2034509216 cites W2121781582 @default.
• W2034509216 cites W2123051564 @default.
• W2034509216 cites W2134144178 @default.
• W2034509216 cites W2148245420 @default.
• W2034509216 cites W4235955770 @default.
• W2034509216 doi "https://doi.org/10.1002/hep.23239" @default.
• W2034509216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19824078" @default.
• W2034509216 hasPublicationYear "2009" @default.
• W2034509216 type Work @default.
• W2034509216 sameAs 2034509216 @default.
• W2034509216 citedByCount "193" @default.
• W2034509216 countsByYear W20345092162012 @default.
• W2034509216 countsByYear W20345092162013 @default.
• W2034509216 countsByYear W20345092162014 @default.
• W2034509216 countsByYear W20345092162015 @default.
• W2034509216 countsByYear W20345092162016 @default.
• W2034509216 countsByYear W20345092162017 @default.
• W2034509216 countsByYear W20345092162018 @default.
• W2034509216 countsByYear W20345092162019 @default.
• W2034509216 countsByYear W20345092162020 @default.
• W2034509216 countsByYear W20345092162021 @default.
• W2034509216 countsByYear W20345092162022 @default.
• W2034509216 countsByYear W20345092162023 @default.
• W2034509216 crossrefType "journal-article" @default.
• W2034509216 hasAuthorship W2034509216A5003360183 @default.
• W2034509216 hasAuthorship W2034509216A5010606656 @default.
• W2034509216 hasAuthorship W2034509216A5011743267 @default.
• W2034509216 hasAuthorship W2034509216A5012100988 @default.
• W2034509216 hasAuthorship W2034509216A5013395050 @default.
• W2034509216 hasAuthorship W2034509216A5020828316 @default.
• W2034509216 hasAuthorship W2034509216A5022042238 @default.
• W2034509216 hasAuthorship W2034509216A5026951492 @default.
• W2034509216 hasAuthorship W2034509216A5071407810 @default.
• W2034509216 hasAuthorship W2034509216A5083171885 @default.
• W2034509216 hasAuthorship W2034509216A5086610543 @default.
• W2034509216 hasBestOaLocation W20345092161 @default.
• W2034509216 hasConcept C126322002 @default.
• W2034509216 hasConcept C134018914 @default.
• W2034509216 hasConcept C141071460 @default.
• W2034509216 hasConcept C142724271 @default.
• W2034509216 hasConcept C168563851 @default.
• W2034509216 hasConcept C204787440 @default.
• W2034509216 hasConcept C27081682 @default.
• W2034509216 hasConcept C2776175330 @default.
• W2034509216 hasConcept C2776954865 @default.
• W2034509216 hasConcept C2777248517 @default.
• W2034509216 hasConcept C2778772119 @default.
• W2034509216 hasConcept C2779134260 @default.
• W2034509216 hasConcept C55493867 @default.
• W2034509216 hasConcept C71924100 @default.
• W2034509216 hasConcept C86803240 @default.
• W2034509216 hasConcept C90924648 @default.
• W2034509216 hasConceptScore W2034509216C126322002 @default.
• W2034509216 hasConceptScore W2034509216C134018914 @default.
• W2034509216 hasConceptScore W2034509216C141071460 @default.
• W2034509216 hasConceptScore W2034509216C142724271 @default.
• W2034509216 hasConceptScore W2034509216C168563851 @default.
• W2034509216 hasConceptScore W2034509216C204787440 @default.
• W2034509216 hasConceptScore W2034509216C27081682 @default.
• W2034509216 hasConceptScore W2034509216C2776175330 @default.
• W2034509216 hasConceptScore W2034509216C2776954865 @default.
• W2034509216 hasConceptScore W2034509216C2777248517 @default.
• W2034509216 hasConceptScore W2034509216C2778772119 @default.
• W2034509216 hasConceptScore W2034509216C2779134260 @default.
• W2034509216 hasConceptScore W2034509216C55493867 @default.

• next